| |
|
      |
|
|
Abstracts
A proposed mechanism for the induction of cytotoxic T lymphocyte
production by heat shock fusion proteins.
Immunity 2000 (March) 12(3): 263-272
Cho B.K.(1), Palliser D.(1), Guillen E.(2), Wisniewski
J.(3), Young R.A.(2), Chen J.(1), Eisen H.N.(1)
1) Center for Cancer Research and Dept. of Biology,
Massachusetts Institute of Technology, Cambridge, MA, USA.
2) The Whitehead Institute, Cambridge, MA, USA.
3) StressGen Biotechnologies Corporation, Victoria, BC, Canada.
A 65 kDa mycobacterial heat shock protein (hsp65),
fused to a polypeptide that contains an octapeptide (SIYRYYGL) agonist
for a particular T cell receptor (2C TCR), stimulated C57BL/6 mice
as well as CD4-deficient mice to produce CD8+ cytolytic T lymphocytes
(CTL) to the fusion partner's octapeptide. This and other hsp65
fusion proteins but not native hsp65 itself stimulated dendritic
cells in vitro and in vivo to upregulate the levels of MHC (class
I and II) and costimulatory (B7.2) molecules. The results suggest
a mechanism for the general finding that hsp fusion proteins, having
fusion partners of widely differing lengths and sequences, elicit
CD8 CTL to peptides from the fusion partners without requiring exogenous
adjuvants or the participation of CD4+ T cells.
|
|